Pfizer to invest $21m in Australian filgrastim plant
Pfizer has said it will invest $21m to expand a plant in Adelaide, Australia which will manufacture a candidate biosimilar version of Amgen’s white blood cell booster, Neulasta.
Archives for March 15, 2016
Sanofi aiming to 'cut years off' vaccine development timelines for Zika says R&D head
Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.
CHO business: Lonza launches reformulated media for biopharma's go-to cell line
Lonza has launched a reformulated CHO media that it says supports the growth of higher density cultures and is easier to filter than currently available products.
CAR T Cell firm Autolus raises £40m in Series B funding
UK-based drug developer Autolus has secured £40m ($57m) to develop its pipeline and license more T-cell engineering technologies from UCL.